Resource cover coming soon

Pharmaceutical Liquid Particle Testing: Configuration Considerations

2026-10-02English

Insoluble-particle testing concerns particle numbers and size-related information. The Klotz brochure describes Syringe® pharmaceutical sensor/software configurations, not an executable pharmacopoeial procedure.[1]

Translate the task into a configuration

Provide the sample and confirmed method, then check sensor range, counting channels, sampling, reports and outputs. LDS 23/25 usp with SW-CA is one pharmaceutical-direction example, not proof of suitability for every pharmaceutical liquid.

Fixed and freely selectable channels represent different software approaches. Required channels come from the method; more channels do not automatically improve decision suitability.

Confirm sample state and data management separately

Available volume, expected particle level and sampling arrangements belong in method definition. Special-sample handling and abnormal signals require model instructions and validated procedures; the brochure is not a basis for universal steps.

Records should identify sample, equipment configuration and method. Report/export functionality does not automatically satisfy every integrity, permission or validation requirement.

Configuration is not the test method

The brochure lacks complete sampling quantities, limits, system-suitability and special-sample requirements. Decisions need the applicable edition, operating documents and confirmed validation evidence.

Configuration establishes the available detection and processing functions; a method additionally specifies sampling, checks and decisions. Confirm both separately.

References